title: Relapse of fungal meningitis associated with contaminated methylprednisolone.
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Smith
authors.forename: Margaret
authors.initials: M
authors.lastname: Tipple
authors.forename: Muddasar N
authors.initials: MN
authors.lastname: Chaudry
authors.forename: Melissa K
authors.initials: MK
authors.lastname: Schaefer
authors.forename: Benjamin J
authors.initials: BJ
authors.lastname: Park
mesh_terms: D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004340:Drug Contamination; D006801:Humans; D007268:Injections, Epidural / Q000009:adverse effects; D008297:Male; D016921:Meningitis, Fungal / Q000188:drug therapy* / Q000209:etiology; D008775:Methylprednisolone / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D011743:Pyrimidines / Q000008:administration & dosage*; D012008:Recurrence; D004718:Saccharomycetales; D014230:Triazoles / Q000008:administration & dosage*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D000077555:Methylprednisolone Acetate; D065819:Voriconazole; D008775:Methylprednisolone